Literature DB >> 29232104

The Effects of Biological Fluids on Colloidal Stability and siRNA Delivery of a pH-Responsive Micellar Nanoparticle Delivery System.

Dominic W Malcolm1,2, Jomy J Varghese1,2, Janet E Sorrells1, Catherine E Ovitt3,4, Danielle S W Benoit1,2,3,4,5.   

Abstract

Nanoparticles (NPs) interact with complex protein milieus in biological fluids, and these interactions have profound effects on NP physicochemical properties and function. Surprisingly, most studies neglect the impact of these interactions, especially with respect to NP-mediated siRNA delivery. Here, the effects of serum on colloidal stability and siRNA delivery of a pH-responsive micellar NP delivery system were characterized. Results show cationic NP-siRNA complexes aggregate in ≥2% serum in buffer, but are stable in serum-free media. Furthermore, nonaggregated NP-siRNA delivered in serum-free media result in 4-fold greater siRNA uptake in vitro, compared to aggregated NP-siRNA. Interestingly, pH-responsive membrane lysis behavior, which is required for endosomal escape, and NP-siRNA dissociation, necessary for gene knockdown, are significantly reduced in serum. Consistent with these data, nonaggregated NP-siRNA in serum-free conditions result in highly efficient gene silencing, even at doses as low as 5 nM siRNA. NP-siRNA diameter was measured at albumin and IgG levels mimicking biological fluids. Neither albumin nor IgG alone induces NP-siRNA aggregation, implicating other serum proteins in NP colloidal instability. Finally, as a proof-of-principle that stability is maintained in established in vivo models, transmission electron microscopy reveals NP-siRNA are taken up by ductal epithelial cells in a nonaggregated state when injected retroductally into mouse salivary glands in vivo. Overall, this study shows serum-induced NP-siRNA aggregation significantly diminishes efficiency of siRNA delivery by reducing uptake, pH-responsive membrane lysis activity, and NP-siRNA dissociation. Moreover, these results highlight the importance of local NP-mediated drug delivery and are broadly applicable to other drug delivery systems.

Entities:  

Keywords:  aggregation; mesenchymal stem cell; micelle; nanoparticle; salivary gland; serum; siRNA

Mesh:

Substances:

Year:  2017        PMID: 29232104      PMCID: PMC5987762          DOI: 10.1021/acsnano.7b05528

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  69 in total

Review 1.  Delivery of siRNA therapeutics: barriers and carriers.

Authors:  Jie Wang; Ze Lu; M Guillaume Wientjes; Jessie L-S Au
Journal:  AAPS J       Date:  2010-06-11       Impact factor: 4.009

2.  Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles.

Authors:  Tommy Cedervall; Iseult Lynch; Stina Lindman; Tord Berggård; Eva Thulin; Hanna Nilsson; Kenneth A Dawson; Sara Linse
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-31       Impact factor: 11.205

3.  Aggregation behavior of cationic nanohydrogel particles in human blood serum.

Authors:  Lutz Nuhn; Sabine Gietzen; Kristin Mohr; Karl Fischer; Kazuko Toh; Kanjiro Miyata; Yu Matsumoto; Kazunori Kataoka; Manfred Schmidt; Rudolf Zentel
Journal:  Biomacromolecules       Date:  2014-04-03       Impact factor: 6.988

Review 4.  Nanoparticles-protein interaction: Role in protein aggregation and clinical implications.

Authors:  Romana Parveen; Tooba Naz Shamsi; Sadaf Fatima
Journal:  Int J Biol Macromol       Date:  2016-10-13       Impact factor: 6.953

5.  Enhanced stability of PEG-block-poly(N-hexyl stearate l-aspartamide) micelles in the presence of serum proteins.

Authors:  Thomas A Diezi; Younsoo Bae; Glen S Kwon
Journal:  Mol Pharm       Date:  2010-08-02       Impact factor: 4.939

6.  Efficacious gene silencing in serum and significant apoptotic activity induction by survivin downregulation mediated by new cationic gemini tocopheryl lipids.

Authors:  Krishan Kumar; Bappa Maiti; Paturu Kondaiah; Santanu Bhattacharya
Journal:  Mol Pharm       Date:  2014-12-18       Impact factor: 4.939

7.  Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface.

Authors:  Anna Salvati; Andrzej S Pitek; Marco P Monopoli; Kanlaya Prapainop; Francesca Baldelli Bombelli; Delyan R Hristov; Philip M Kelly; Christoffer Åberg; Eugene Mahon; Kenneth A Dawson
Journal:  Nat Nanotechnol       Date:  2013-01-20       Impact factor: 39.213

8.  Fluid phase endocytosis contributes to transfection of DNA by PEI-25.

Authors:  Hansjörg Hufnagel; Parvez Hakim; Aline Lima; Florian Hollfelder
Journal:  Mol Ther       Date:  2009-06-16       Impact factor: 11.454

9.  Effect of cell media on polymer coated superparamagnetic iron oxide nanoparticles (SPIONs): colloidal stability, cytotoxicity, and cellular uptake studies.

Authors:  Alke Petri-Fink; Benedikt Steitz; Andrija Finka; Jatuporn Salaklang; Heinrich Hofmann
Journal:  Eur J Pharm Biopharm       Date:  2007-07-13       Impact factor: 5.571

10.  Evaluating side effects of nanoparticle-mediated siRNA delivery to mesenchymal stem cells using next generation sequencing and enrichment analysis.

Authors:  Dominic W Malcolm; Janet E Sorrells; Daniel Van Twisk; Juilee Thakar; Danielle S W Benoit
Journal:  Bioeng Transl Med       Date:  2016-10-24
View more
  11 in total

1.  Retroductal Nanoparticle Injection to the Murine Submandibular Gland.

Authors:  Jomy J Varghese; Isaac L Schmale; Yuchen Wang; Mollie Eva Hansen; Shawn D Newlands; Catherine E Ovitt; Danielle S W Benoit
Journal:  J Vis Exp       Date:  2018-05-03       Impact factor: 1.355

2.  Enhanced design and formulation of nanoparticles for anti-biofilm drug delivery.

Authors:  Kenneth R Sims; Yuan Liu; Geelsu Hwang; Hoi In Jung; Hyun Koo; Danielle S W Benoit
Journal:  Nanoscale       Date:  2018-12-20       Impact factor: 7.790

3.  Amniotic fluid stabilized lipid nanoparticles for in utero intra-amniotic mRNA delivery.

Authors:  Kelsey L Swingle; Margaret M Billingsley; Sourav K Bose; Brandon White; Rohan Palanki; Apeksha Dave; Savan K Patel; Ningqiang Gong; Alex G Hamilton; Mohamad-Gabriel Alameh; Drew Weissman; William H Peranteau; Michael J Mitchell
Journal:  J Control Release       Date:  2021-11-03       Impact factor: 9.776

4.  Degradable poly(ethylene glycol) (PEG)-based hydrogels for spatiotemporal control of siRNA/nanoparticle delivery.

Authors:  Yuchen Wang; Sue Zhang; Danielle S W Benoit
Journal:  J Control Release       Date:  2018-08-03       Impact factor: 9.776

Review 5.  Development of controlled drug delivery systems for bone fracture-targeted therapeutic delivery: A review.

Authors:  Yuchen Wang; Maureen R Newman; Danielle S W Benoit
Journal:  Eur J Pharm Biopharm       Date:  2018-02-19       Impact factor: 5.571

6.  Endosomal Organization of CpG Constructs Correlates with Enhanced Immune Activation.

Authors:  Kwahun Lee; Ziyin N Huang; Chad A Mirkin; Teri W Odom
Journal:  Nano Lett       Date:  2020-07-31       Impact factor: 11.189

7.  Rigor and reproducibility in polymer nanoparticle synthesis and characterization.

Authors:  Kenneth R Sims; Julian P Maceren; Alexander Ian Strand; Brian He; Clyde Overby; Danielle S W Benoit
Journal:  RSC Adv       Date:  2020-01-14       Impact factor: 4.036

Review 8.  The Hitchhiker's Guide to Human Therapeutic Nanoparticle Development.

Authors:  Thelvia I Ramos; Carlos A Villacis-Aguirre; Katherine V López-Aguilar; Leandro Santiago Padilla; Claudia Altamirano; Jorge R Toledo; Nelson Santiago Vispo
Journal:  Pharmaceutics       Date:  2022-01-21       Impact factor: 6.321

9.  Guiding Appropriate Timing of Laser Irradiation by Polymeric Micelles for Maximizing Chemo-Photodynamic Therapy.

Authors:  Yun Zhu; Fangying Yu; Yanan Tan; Lijuan Wen; Yinghong Li; Hong Yuan; Fuqiang Hu
Journal:  Int J Nanomedicine       Date:  2020-08-31

Review 10.  Interactions at the cell membrane and pathways of internalization of nano-sized materials for nanomedicine.

Authors:  Valentina Francia; Daphne Montizaan; Anna Salvati
Journal:  Beilstein J Nanotechnol       Date:  2020-02-14       Impact factor: 3.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.